An Exploratory Genetic Study in Participants With Psoriasis

Completed

Conditions studied: Psoriasis

In brief

The purpose of this study is to evaluate the association between genetic factors and response to treatment (guselkumab, ustekinumab, adalimumab, or etanercept) and psoriasis (scaly skin rash).

Key facts

Study ID

NCT02155192

Run by

Janssen Research & Development, LLC

People needed

712

Starts

2014-03-01

Expected to finish

2014-09-01

Last updated by the study team

2014-11-03

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Participants must have been randomly assigned and treated in the NCT01483599 (X-PLORE), NCT00267969 (PHOENIX 1), NCT00307437 (PHOENIX-2) , or NCT00454584 (ACCEPT) studies
• Sign an informed consent document indicating that they understand the purpose of and procedures required for this study and are willing to participate in this study

You may not qualify if…

• Participants has any condition for which, in the opinion of the investigator, participation would not be in the best interest of the subject (for example, compromise the well-being) or that could prevent, limit, or confound the protocol-specified assessments

Where it is running

• Study site — Bakersfield, California, United States
• Study site — Los Angeles, California, United States
• Study site — Ocala, Florida, United States
• Study site — Alpharetta, Georgia, United States
• Study site — Arlington Heights, Illinois, United States
• Study site — Indianapolis, Indiana, United States
• Study site — Louisville, Kentucky, United States
• Study site — Andover, Massachusetts, United States
• Study site — St Louis, Missouri, United States
• Study site — New York, New York, United States
• Study site — Portland, Oregon, United States
• Study site — Webster, Texas, United States
• Study site — Moncton, New Brunswick, Canada
• Study site — Hamilton, Ontario, Canada
• Study site — London, Ontario, Canada
• Study site — Toronto, Ontario, Canada
• Study site — Waterloo, Ontario, Canada
• Study site — Montreal, Quebec, Canada
• Study site — Québec, Quebec, Canada

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.